Expert Perspectives on the Clinical Impact of Non-Medical Therapeutic Switching

Adam Friedman, MD, FAAD provides insight into how and why insurance companies implement non-medical therapeutic switching and what healthcare providers can do to mitigate its impact on patient care.
x